Home>Topics>>Therapeutic Proteins Offer New Investment Opportunities
Therapeutic Proteins Offer New Investment Opportunities
Healthcare Sector and Stocks Analysis from Seeking Alpha
Sat, 24 Nov 2012
By Cris Frangold : A few days ago, Prolor Biotech ( PBTH ) was downgraded by research analysts at Summer Street from a "buy" rating to a "sell" rating. Summer Street now has a $3.00 target price on the stock, down from their previous target price of $6.00. The stock is trading at around $4.42 with ...